Skip to main content

Table 1 Basic characteristics of the study participants

From: Vitamin D receptor gene polymorphisms affecting changes in visceral fat, waist circumference and lipid profile in breast cancer survivors supplemented with vitamin D3

Characteristics Total
Age 50(43–55)
Current smoking, N (%) 1(1)
Hormone receptor status, N (%)
 ER+ 89(60)
 ER + PR+ 83(56)
 ER + PR- 5(3)
 ER-PR- 35(23)
 HER2+ 12(8)
 ER-PR-HER2- 18(12)
Family history of breast cancer, N (%) 25(17)
Post-menopausal, N (%) 111(76)
Hormone therapy for breast cancer 112(76)
Stage, N (%)
 Stage I 33(22)
 Stage II 61(41)
 Stage III 35(24)
 Missing 18(13)
Recurrence N (%)
 Yes 5(3)
 No 77(67)
 Unknown 65(30)
Physical activity levels, N (%)
 Low physical activity 80(54)
 Moderate physical activity 44(30)
 High physical activity 23(16)
Energy intake, Kcal 1901(1832–2046)
Fat intake, grams 84 ± 16
Protein intake, grams 56(49–62)
Carbohydrate intake, grams 243 ± 41
Pre intervention Vitamin D, nmol/liter 38(22–62)
Post intervention vitamin D, nmol/liter 110 ± 46
ApaI N (%)
 AA 68(49)
 Aa 52(38)
 aa 18(13)
TaqI N (%)
 TT 57(41)
 Tt 67(49)
 tt 14(10)
BsmI N (%)
 BB 66(45)
 Bb 65(44)
 bb 16(11)
FokI N (%)
 FF 64(44)
 Ff 66(45)
 ff 17(12)
Cdx2 N (%)
 GG 81(55)
 AG 52(35)
 AA 14(10)
  1. ER Estrogen Receptor, PR Progesterone Receptor, HER2 Human Epidermal Growth Factor Receptor 2, BMI Body Mass Index, BMI Body Mass Index, WC Waist Circumference, HC Hip Circumference
  2. Values with normal distribution are presented as mean ± SD, values with non-normal distribution as median (Q1, Q3) and categorical variables as N (%)